Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.51 USD | -1.34% | -0.95% | -21.22% |
Apr. 25 | Top Premarket Gainers | MT |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2024 * | 24.07M | Sales 2025 * | 42.86M | Capitalization | 57.07M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -40M | EV / Sales 2024 * | 2.37 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.33 x |
P/E ratio 2024 * |
-0.97
x | P/E ratio 2025 * |
-2.29
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | -1.34% | ||
1 week | -0.95% | ||
Current month | +4.42% | ||
1 month | -42.08% | ||
3 months | -10.52% | ||
6 months | -22.78% | ||
Current year | -21.22% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 12.51 | -1.34% | 54,051 |
24-05-02 | 12.68 | +7.37% | 65,150 |
24-05-01 | 11.81 | -1.42% | 107,666 |
24-04-30 | 11.98 | -2.80% | 76,446 |
24-04-29 | 12.32 | -2.41% | 112,391 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.22% | 57.07M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- CDTX Stock